Company profile
iTeos Therapeutics, Inc. Insider Trading
ITOSEvery SEC Form 4 insider trading filing for iTeos Therapeutics, Inc. (ITOS) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Sector
- Biological Products, (No Diagnostic Substances)
- CIK
- 0001808865
- Filings
- 53
- Insiders
- 38
- Last filing
- 2025-08-29
Activity summary
No insider transactions in the last 30 days. The most recent was on August 29, 2025, when Matthew Call sold 161,898 shares. 53 filings from 38 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q2 23 to Q2 25. iTeos Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $120.0M.
No insider activity recorded for ITOS in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 29, 2025 | Matthew Call | ITOS | U | 161,898 | — | — |
| Aug 29, 2025 | Matthew Call | ITOS | Disposition | 9,063 | — | — |
| Aug 29, 2025 | Matthew Call | ITOS | Disposition | 135,937 | — | — |
| Aug 29, 2025 | Matthew Call | ITOS | Disposition | 41,694 | — | — |
| Aug 29, 2025 | Matthew Call | ITOS | Disposition | 66,170 | — | — |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=ITOS" \
-H "X-Api-Key: $KEY"